0 results

Patient Corner

Anatomical Illustrations

More

Last reference updates

  • Jul 18, 2016 - MedWatch Drug Updates

Recall of Oral Liquid Docusate Sodium by PharmaTech- Possible microbial contamination

PharmaTech recalled oral liquid docusate sodium because of possible contamination with Burkholderia cepacia

Read more
  • Jul 13, 2016 - FDA Drug Updates

FDA approved Xiidra (lifitegrast) for dry eye disease

FDA approved Xiidra (lifitegrast), the first lymphocyte function-associated antigen 1 (LFA-1) antagonist for dry eye disease

Read more
  • Jul 13, 2016 - FDA Drug Updates

Recall of INRatio and INRatio2 PT/INR monitor system by Alere due to inaccurate INR results

Alere is initiating recall of INRatio and INRatio2 PT/INR Monitor System due to inaccurate INR results

Read more
  • Jun 30, 2016 - MedWatch Drug Updates

Class I Recall of HeartWare Ventricular Assist Device (HVAD) Batteries due to premature power depletion

Class I Recall of HeartWare Ventricular Assist Device (HVAD) Batteries as they may lose power prematurely due to faulty cells

Read more
  • Jun 29, 2016 - FDA Drug Updates

FDA approved Epclusa (sofosbuvir/velpatasvir) for chronic hepatitis C infection

FDA approved Epclusa (sofosbuvir/velpatasvir) for treatment of all six major forms of chronic hepatitis C infection

Read more
  • Jun 24, 2016 - FDA Drug Updates

FDA approved Rayaldee (calcifediol) for secondary hyperparathyroidism

FDA approved Rayaldee (calcifediol) for secondary hyperparathyroidism associated with vitamin D insufficiency in stage 3-4 chronic kidney disease

Read more
  • Jun 15, 2016 - MedWatch Drug Updates

Canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR) may increase the risk for acute kidney failure

FDA strengthens the existing kidney warning for the type 2 diabetes medicines canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR).

Read more
  • Jun 9, 2016 - MedWatch Drug Updates

Recall of Nature Made products by Pharmavite LLC - Possible microbial contamination

Pharmavite recalled Nature Made products because of possible Salmonella or Staphylococcus aureus contamination

Read more
  • Jun 8, 2016 - MedWatch Drug Updates

Loperamide (Imodium): risk of serious heart problems with high doses from abuse and misuse

Serious heart problems, including death linked to abuse of antidiarrheal medication loperamide

Read more
  • Jun 7, 2016 - MedWatch Drug Updates

Drug Safety alert: Risk of serious bleeding with OTC, aspirin-containing antacid products

Serious bleeding risk associated with the use of OTC aspirin-containing antacid products

Read more